If you’ve been struggling to fill your prescription for an estradiol patch, you’re not imagining it. Demand for menopause hormone therapy has surged since the FDA removed the long-standing “boxed warning” from hormone therapy labels in late 2025, and manufacturers haven’t been able to scale production fast enough to keep up. The FDA says patches are still available overall, but availability now varies significantly by brand, dose, and pharmacy.
If your usual patch is out of stock, here’s what’s driving the shortage and what your options are.
Why did demand suddenly spike?
For years, hormone replacement therapy labels carried a boxed warning, the FDA’s strongest label warning, citing risks including cardiovascular disease, breast cancer, and dementia. That warning was based largely on older research and had long been considered outdated by many menopause specialists, who felt it discouraged appropriate use in women who could genuinely benefit.
When the FDA removed that warning, many women who had been hesitant to start hormone therapy became willing to try it, and many providers became more comfortable prescribing it. According to data from Epic Research, HRT prescriptions for women ages 50 to 65 have risen roughly 86% since 2021. That increase, combined with a genuinely complex manufacturing process for hormone patches, has outpaced what suppliers can currently produce.
Who makes these patches, and what are they saying?
Estradiol transdermal patches are manufactured by several companies, including Amneal, Sandoz, Noven, Bayer, Zydus, and Viatris. The FDA is actively working with manufacturers to increase supply. Some manufacturers have been direct about the challenge: Bayer has said one of its Climara patch doses will have supply constraints into early 2027, and other manufacturers have described the specialized equipment required to produce patches as slow to scale.
Does this mean menopause patches are unavailable?
Not entirely. The FDA maintains that estradiol transdermal patches are still available overall, but which brand, dose, or delivery method you can actually get may depend on your specific pharmacy and location. This is different from a total shortage, it’s more of an uneven, hard-to-predict supply picture.
What should you do if your pharmacy is out of your usual patch?
A few practical steps:
- Call around to a few pharmacies before assuming it’s unavailable everywhere, since stock varies significantly by location.
- Ask your provider about alternative formulations. Estrogen is available in multiple delivery methods, patches, oral tablets, topical gels or creams, and vaginal formulations, depending on your symptoms and goals.
- Don’t stop hormone therapy abruptly without a plan, since discontinuing suddenly can bring symptoms back quickly. Talk to your provider about bridging options if your specific patch isn’t available.
- Ask about compounded alternatives, which may be an option depending on your provider and pharmacy access.
Is switching formulations a problem?
Not necessarily, though it’s worth doing with provider guidance rather than guessing on your own. Different delivery methods (patch vs. oral vs. topical) can have different absorption patterns and considerations, so a provider can help you choose an alternative that still fits your health profile and goals if your usual option isn’t available.
FAQs
Is this shortage specific to one brand?
No, multiple manufacturers have reported constraints on specific doses or products, though availability varies. It’s not limited to a single company’s product line.
Will the shortage get better soon?
Manufacturers are actively working to increase capacity, though some, like Bayer, have indicated certain constraints could continue into early 2027. Timelines vary by manufacturer and specific product.
Should I switch off patches permanently because of this?
Not necessarily. Many women switch temporarily during a supply gap and return to their preferred formulation once it’s available again. This is a conversation to have with your provider based on your symptoms and preferences.
Can an online hormone therapy provider help me navigate this?
Yes. An online hormone therapy provider can help you explore alternative formulations, doses, or delivery methods based on what’s actually available, rather than leaving you to figure it out alone.
The bottom line
The current menopause patch shortage is real, driven by a genuine surge in demand after the FDA removed the boxed warning, not a sign that something is wrong with the medication itself. If your usual patch isn’t available, you have real alternatives to discuss with a provider instead of going without treatment or guessing on your own.
Struggling to find your prescription, or thinking about starting hormone therapy for the first time? Schedule a consultation with TBTotal.Health and let a licensed provider help you find the right option.
Hormone therapy should only be started, adjusted, or discontinued under medical supervision. Individual results vary. Medication availability is subject to change based on manufacturer supply.
